Researchers at Duke Medicine say that there are notable differences between the effectiveness and safety results of aldosterone antagonist therapy in clinical trial versus what occurs in actual practice. Those differences have been noted anecdotally by doctors, and likely contributed to the slow adoption of aldosterone antagonists in clinical practice, but they had not been confirmed in a large study examining the drugs in real-world situations. The ...
via Medindia Health News More READ
No comments:
Post a Comment